Security Datasheet

OpticPrep™ PreSaturated Wipe (UFI)
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Commission Regulation (EU)
2020/878
SECTION 11: Toxicological information
Potential acute health effects
Inhalation
:
Can cause central nervous system (CNS) depression. May cause drowsiness or
dizziness.
Can cause central nervous system (CNS) depression.
:
Ingestion
Skin contact
:
May cause skin irritation.
Causes serious eye irritation.
:
Eye contact
Carcinogenicity
Conclusion/Summary
:
Not available.
Mutagenicity
Conclusion/Summary
:
Not available.
Teratogenicity
Conclusion/Summary
:
Not available.
Reproductive toxicity
Conclusion/Summary
:
Not available.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Inhalation
Adverse symptoms may include the following:
nausea or vomiting
headache
drowsiness/fatigue
dizziness/vertigo
unconsciousness
Adverse symptoms may include the following:
cracking
dryness
redness
:
:
Eye contact
:
Adverse symptoms may include the following:
pain or irritation
watering
redness
propan-2-ol
Eyes - Moderate irritant
Rabbit
-
10 mg
-
Eyes - Moderate irritant
Rabbit
-
24 hours 100
mg
-
Eyes - Severe irritant
Rabbit
-
100 mg
-
Skin - Mild irritant
Rabbit
-
500 mg
-
Product/ingredient name
Result
Score
Exposure
Observation
Conclusion/Summary
:
Not available.
Sensitisation
Conclusion/Summary
:
Not available.
Species
Not available.
Specific target organ toxicity (single exposure)
Specific target organ toxicity (repeated exposure)
Product/ingredient name
Category
Aspiration hazard
Route of
exposure
Target organs
Information on likely routes
of exposure
:
Not available.
propan-2-ol
Category 3
-
Narcotic effects
Not available.
Date of issue/Date of revision
:
1/17/2023
Date of previous issue
:
1/17/2023
Version
:
57
10/15